A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
about
A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A polymorphism in the type one ...... that inhibits ligand binding.
@en
type
label
A polymorphism in the type one ...... that inhibits ligand binding.
@en
prefLabel
A polymorphism in the type one ...... that inhibits ligand binding.
@en
P2093
P2860
P1433
P1476
A polymorphism in the type one ...... n that inhibits ligand binding
@en
P2093
Brad H Rovin
Daniel J Birmingham
Haikady N Nagaraja
Katherine F Gavit
Lee A Hebert
P2860
P304
P356
10.1016/J.MOLIMM.2007.03.007
P577
2007-04-30T00:00:00Z